✦ LIBER ✦

A phase I and pharmacokinetic study of DE-310 administered as a 3 hour infusion every 4 weeks (wks) to patients (pts) with advanced solid tumors or lymphomas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

550 Phase I and pharmacokinetic (PK) stu

✍ S.Q. Chu; G. Schwartz; M. Beeram; A. Patniak; M. Mita; J. Jimeno; L. Lopez-Laraz 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 273 KB

Phase I dose-escalating study of ES-285

✍ C. Massard, R. Salazar, J. P. Armand, M. Majem, E. Deutsch, M. García, A. Oaknin 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 591 KB

529 Nonlinear pharmacokinetic modeling o

✍ C. Hsu; T. Chen; A. Mita; A.C. Lockhart; M. Moricz; L. Alland; G. Taccard; E. Ro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 140 KB

27 ORAL Phase I dose escalation study of

✍ M. De Jonge; N. Steeghs; J. Verweij; J.W.R. Nortier; F. Eskens; J. Ouwerkerk; C. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 82 KB

212 POSTER A Phase I study of huC242-DM4

✍ A.W. Tolcher; A. Ricart; J. Rodon; A. Patnaik; A. Mita; M. Mita; S. Sarantopolus 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 66 KB

Phase I and pharmacokinetic study of Yon

✍ C. Twelves; K. Hoekman; A. Bowman; J.B. Vermorken; A. Anthoney; J. Smyth; C. van 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 279 KB